speb/financial-data huggingface dataset:
Financial ratios for IGC — quarterly report dated 2025-09-30
Total revenue: 191000
Gross profit: 99000
Operating income: -2899000
Net income: -1821000
Capital expenditures: 52000
Operating cash flow: -2090000
Depreciation & amortization: 119000
Net tangible assets: 3213000
Owner earnings: -1754000
Return on net tangible assets (%): -54.590725178960476
Buffett classification: The Gruesome
Stock price: 0.42
Shares outstanding: 104366170
Book value: 8092000
P/B ratio: 5.416929238754324
Market cap (USD): 43833791.4
Debt to equity: 0.018042511122095897
Current ratio: 1.323645970937913
Quick ratio: 0.8890356671070013
COGS to revenue (%): 48.167539267015705
R&D to revenue (%): 831.413612565445
SG&A to revenue (%): 738.2198952879581
Free cash flow (dilution-adjusted): -3146000
Buyback yield (%): 0
Retained earnings: -122828000
Inventory turnover: 0.1398176291793313
Receivables turnover: 3.1311475409836067
Capitalized R&D asset: 2487180
ROCI (R&D-adjusted, %): -22.92172521675945
Rosenberg metric: -0.06462984723854288
FCF margin (%): -1647.1204188481674
Revenue growth (%): -41.76829268292683
Rule of 40 score: -1688.8887115310943
Financial ratios for IGC — quarterly report dated 2025-12-31
Total revenue: 350000
Gross profit: 44000
Operating income: -2941000
Net income: -726000
Capital expenditures: 10000
Operating cash flow: -1223000
Depreciation & amortization: 64000
Net tangible assets: 2322000
Owner earnings: -672000
Return on net tangible assets (%): -28.940568475452196
Buffett classification: The Gruesome
Stock price: 0.28
Shares outstanding: 104366170
Book value: 7423000
P/B ratio: 3.93675435807625
Market cap (USD): 29222527.6
Debt to equity: 0.019129731914320356
Current ratio: 0.8302411873840445
Quick ratio: 0.5333951762523191
COGS to revenue (%): 87.42857142857143
R&D to revenue (%): 423.4285714285714
SG&A to revenue (%): 429.42857142857144
Free cash flow (dilution-adjusted): -2354000
Buyback yield (%): 0
Retained earnings: -124890000
Inventory turnover: 0.478125
Receivables turnover: 4.666666666666667
Capitalized R&D asset: 2826790
ROCI (R&D-adjusted, %): -26.640238317446467
Rosenberg metric: -0.034634760705289674
FCF margin (%): -672.5714285714286
Revenue growth (%): 83.24607329842932
Rule of 40 score: -589.3253552729992
Financial ratios for JPM.TO — quarterly report dated 2025-12-31
Total revenue: 33427737226.27737
Net income: 9507299270.072992
Capital expenditures: 0
Operating cash flow: 87389781021.8978
Depreciation & amortization: 1687591240.8759122
Net tangible assets: 217503649635.03647
Owner earnings: 11194890510.948904
Return on net tangible assets (%): 5.14698973085442
Buffett classification: The Gruesome
Stock price: 30.124087591240876
P/E ratio: 20.07061072616453
Shares outstanding: 27344329837
Book value: 264553284671.5332
P/B ratio: 3.1136373458991287
Market cap (USD): 823722987133.5693
Debt to equity: 1.379496631147946
Effective tax rate (%): 24.096736596736594
COGS to revenue (%): 0
SG&A to revenue (%): 31.849943226482658
Free cash flow (dilution-adjusted): 87389781021.8978
Buyback yield (%): 0.7322991931197665
Retained earnings: 303689781021.89777
Receivables turnover: 0.4103621000188174
Capitalized R&D asset: 0
FCF margin (%): 261.42894575945496
Revenue growth (%): 0.07442331364536446
Rule of 40 score: 261.5033690731003
Financial ratios for JPM.TO — annual report dated 2025-12-31
Total revenue: 132735036496.35036
Net income: 41640875912.40875
Capital expenditures: 0
Operating cash flow: -107870072992.70071
Depreciation & amortization: 6438686131.386861
Net tangible assets: 217503649635.03647
Owner earnings: 48079562043.795616
Return on net tangible assets (%): 22.10517484394926
Buffett classification: The Gruesome
Stock price: 30.124087591240876
P/E ratio: 19.781596065996883
Shares outstanding: 27344329837
Book value: 264553284671.5332
P/B ratio: 3.1136373458991287
Market cap (USD): 823722987133.5693
Debt to equity: 1.379496631147946
Effective tax rate (%): 21.41607548729251
COGS to revenue (%): 0
SG&A to revenue (%): 33.004668760001536
Free cash flow (dilution-adjusted): -107870072992.70071
Buyback yield (%): 3.065217980300804
Retained earnings: 303689781021.89777
Receivables turnover: 1.6294680059857167
Capitalized R&D asset: 0
FCF margin (%): -81.2672191457654
Revenue growth (%): 12.023266302197849
Rule of 40 score: -69.24395284356754
Financial ratios for KLR.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.10986486486486488
Shares outstanding: 68121123
Market cap (USD): 7484117.972837839
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KLR.L — annual report dated 2022-12-31
Total revenue: 3547710843.373494
Gross profit: 2277469879.5180726
Operating income: 116265060.24096386
Net income: 55421686.746987954
Capital expenditures: 88433734.93975905
Operating cash flow: 66024096.38554217
Depreciation & amortization: 135783132.5301205
Net tangible assets: 429638554.2168675
Owner earnings: 102771084.33734939
Return on net tangible assets (%): 23.920358945597304
Capex to operating income (%): 76.06217616580311
Buffett classification: The Gruesome
Stock price: 0.08349397590361446
P/E ratio: 0.10262595269347825
Shares outstanding: 68121123
Book value: 598554216.86747
P/B ratio: 0.009502403027173912
Market cap (USD): 5687703.402289157
Debt to equity: 0.8051529790660225
Current ratio: 1.3750861237425933
Quick ratio: 1.2036654264847733
Effective tax rate (%): 20.071047957371228
Interest coverage ratio: 6.185897435897436
COGS to revenue (%): 35.80452353460572
Free cash flow (dilution-adjusted): -32409638.55421687
Buyback yield (%): 25.419453692824938
Retained earnings: 393614457.8313253
Inventory turnover: 8.47508038585209
Receivables turnover: 4.784077985377742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.878186098884226
FCF margin (%): -0.913536643347144
Rule of 40 score: -0.913536643347144
Financial ratios for KLR.L — annual report dated 2023-12-31
Total revenue: 3754430379.746835
Gross profit: 2546835443.0379744
Operating income: 215443037.97468352
Net income: 113670886.07594936
Capital expenditures: 92911392.40506329
Operating cash flow: 249367088.60759494
Depreciation & amortization: 148481012.65822783
Net tangible assets: 507215189.8734177
Owner earnings: 169240506.3291139
Return on net tangible assets (%): 33.366608435238334
Capex to operating income (%): 43.12573443008226
Buffett classification: The Good
Stock price: 0.10177215189873415
P/E ratio: 0.060990404111358566
Shares outstanding: 68121123
Book value: 655696202.5316455
P/B ratio: 0.01057323994054054
Market cap (USD): 6932833.277468353
Debt to equity: 0.7503861003861003
Current ratio: 1.3257142857142856
Quick ratio: 1.1987755102040814
Effective tax rate (%): 28.503184713375795
Interest coverage ratio: 5.808873720136519
COGS to revenue (%): 32.16453135536075
Free cash flow (dilution-adjusted): 129746835.44303797
Buyback yield (%): 62.0784792610221
Retained earnings: 473291139.2405063
Inventory turnover: 10.225080385852088
Receivables turnover: 5.086606070999828
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.062188262761328
FCF margin (%): 3.4558327714093053
Revenue growth (%): 5.8268428713534295
Rule of 40 score: 9.282675642762735
Financial ratios for KLR.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 603125000
Buffett classification: The Gruesome
Stock price: 0.17124999999999996
Shares outstanding: 68121123
Book value: 745875000
P/B ratio: 0.015640344982403215
Market cap (USD): 11665742.313749997
Debt to equity: 0.5607507960449137
Current ratio: 1.409729586426299
Quick ratio: 1.3015641569459173
Buyback yield (%): 0
Retained earnings: 582250000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KLR.L — annual report dated 2024-12-31
Total revenue: 3733375000
Gross profit: 2690000000
Operating income: 245000000
Net income: 178375000
Capital expenditures: 75000000
Operating cash flow: 332375000
Depreciation & amortization: 140125000
Net tangible assets: 603125000
Owner earnings: 243500000
Return on net tangible assets (%): 40.373056994818654
Capex to operating income (%): 30.612244897959183
Buffett classification: The Good
Stock price: 0.17124999999999996
P/E ratio: 0.06540009706377013
Shares outstanding: 68121123
Book value: 745875000
P/B ratio: 0.015640344982403215
Market cap (USD): 11665742.313749997
Debt to equity: 0.5607507960449137
Current ratio: 1.409729586426299
Quick ratio: 1.3015641569459173
Effective tax rate (%): 22.403480152256662
Interest coverage ratio: 7.0503597122302155
COGS to revenue (%): 27.94723273177755
SG&A to revenue (%): 0.12388254595372819
Free cash flow (dilution-adjusted): 221125000
Buyback yield (%): 215.37420700940783
Retained earnings: 582250000
Inventory turnover: 10.229166666666666
Receivables turnover: 5.193357676925752
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.913442053459423
FCF margin (%): 5.922924967355275
Revenue growth (%): -0.5608142279163801
Rule of 40 score: 5.362110739438895
Financial ratios for KLR.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 648219178.0821918
Buffett classification: The Gruesome
Stock price: 0.1932876712328767
Shares outstanding: 68121123
Book value: 792739726.0273974
P/B ratio: 0.016609453007257646
Market cap (USD): 13166973.226438357
Debt to equity: 0.5358562294798686
Current ratio: 1.4509508824736628
Quick ratio: 1.3082501026132167
Buyback yield (%): 0
Retained earnings: 660547945.2054795
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIMN — quarterly report dated 2025-06-30
Capital expenditures: 0
Operating cash flow: -8816466
Depreciation & amortization: 743
Buffett classification: The Gruesome
Stock price: 11.15
Shares outstanding: 67160362
Market cap (USD): 748838036.3000001
Free cash flow (dilution-adjusted): -8816466
Buyback yield (%): 0
Capitalized R&D asset: 110.22
Rule of 40 score: 0
Financial ratios for LIMN — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -701170
Net income: -1823351
Capital expenditures: 0
Operating cash flow: -600612
Depreciation & amortization: 542
Net tangible assets: -1645763
Owner earnings: -1822809
Buffett classification: The Gruesome
Stock price: 1.67
Shares outstanding: 67160362
Book value: -1645763
Market cap (USD): 112157804.53999999
Debt to equity: -0.8764931524162349
Current ratio: 0.4200841096798044
Quick ratio: 0.4200841096798044
Interest coverage ratio: -36.8029603191266
Free cash flow (dilution-adjusted): -613720
Buyback yield (%): 0
Retained earnings: -30702806
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIMN — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -884211
Net income: -8168927
Capital expenditures: 0
Operating cash flow: -386847
Depreciation & amortization: 543
Net tangible assets: -9814690
Owner earnings: -8168384
Buffett classification: The Gruesome
Stock price: 0.61
Shares outstanding: 67160362
Book value: -9814690
Market cap (USD): 40967820.82
Debt to equity: -0.14697356717328822
Current ratio: 0.048607718541448
Quick ratio: 0.048607718541448
Interest coverage ratio: -46.41283922103827
Free cash flow (dilution-adjusted): -386847
Buyback yield (%): 0
Retained earnings: -38871733
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LIMN — annual report dated 2025-12-31
Total revenue: 0
Operating income: -2967812
Net income: -10206517
Capital expenditures: 13108
Operating cash flow: -9963318
Depreciation & amortization: 1828
Net tangible assets: -9814690
Owner earnings: -10217797
Buffett classification: The Gruesome
Stock price: 0.61
Shares outstanding: 67160362
Book value: -9814690
Market cap (USD): 40967820.82
Debt to equity: -0.14697356717328822
Current ratio: 0.048607718541448
Quick ratio: 0.048607718541448
Interest coverage ratio: -13.746043362065372
Free cash flow (dilution-adjusted): -9976426
Buyback yield (%): 0
Retained earnings: -38871733
Capitalized R&D asset: 3038983.7800000003
Rule of 40 score: 0
Financial ratios for LUCE.L — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1891891.8918918918
Buffett classification: The Gruesome
Stock price: 0.03945945945945946
Shares outstanding: 147190257
Market cap (USD): 5808047.978918918
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LUCE.L — annual report dated 2022-12-31
Total revenue: 248554216.86746988
Gross profit: 81927710.84337349
Operating income: 15301204.81927711
Net income: 13253012.048192771
Capital expenditures: 4698795.180722891
Operating cash flow: 46506024.096385546
Depreciation & amortization: 10722891.566265061
Net tangible assets: 54216867.46987952
Owner earnings: 19277108.43373494
Return on net tangible assets (%): 35.55555555555555
Capex to operating income (%): 30.70866141732283
Buffett classification: The Good
Stock price: 0.010361445783132531
P/E ratio: 0.11507601910909092
Shares outstanding: 147190257
Book value: 104457831.32530122
P/B ratio: 0.014600186968858132
Market cap (USD): 1525103.8677108434
Debt to equity: 0.4002306805074971
Current ratio: 1.988909426987061
Quick ratio: 1.1109057301293899
Effective tax rate (%): 5.982905982905982
Interest coverage ratio: 6.35
COGS to revenue (%): 67.03829374697044
SG&A to revenue (%): 25.35142995637421
Free cash flow (dilution-adjusted): 38313253.0120482
Buyback yield (%): 189.5979891127308
Retained earnings: 81807228.91566266
Inventory turnover: 2.911578947368421
Receivables turnover: 4.093253968253968
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.24193548387097
FCF margin (%): 15.41444498303442
Rule of 40 score: 15.41444498303442
Financial ratios for LUCE.L — annual report dated 2023-12-31
Total revenue: 264556962.02531645
Gross profit: 104810126.58227848
Operating income: 28101265.822784808
Net income: 21139240.50632911
Capital expenditures: 8101265.822784809
Operating cash flow: 36708860.75949367
Depreciation & amortization: 11772151.898734177
Net tangible assets: 67974683.54430379
Owner earnings: 24810126.582278475
Return on net tangible assets (%): 36.49906890130353
Capex to operating income (%): 28.82882882882883
Buffett classification: The Good
Stock price: 0.014303797468354428
P/E ratio: 0.09959580264071856
Shares outstanding: 147190257
Book value: 118734177.21518987
P/B ratio: 0.01773187531023454
Market cap (USD): 2105379.6254430376
Debt to equity: 0.2921108742004264
Current ratio: 2.0214007782101167
Quick ratio: 1.2276264591439687
Effective tax rate (%): 11.640211640211641
Interest coverage ratio: 6.7272727272727275
COGS to revenue (%): 60.382775119617214
SG&A to revenue (%): 28.995215311004785
Free cash flow (dilution-adjusted): 25316455.69620253
Buyback yield (%): 96.19720981530885
Retained earnings: 97215189.87341772
Inventory turnover: 3.093137254901961
Receivables turnover: 3.928571428571429
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.70334928229665
FCF margin (%): 9.569377990430622
Revenue growth (%): 6.438331789148159
Rule of 40 score: 16.007709779578782
Financial ratios for LUCE.L — annual report dated 2024-12-31
Total revenue: 303125000
Gross profit: 121875000
Operating income: 29000000
Net income: 18250000
Capital expenditures: 6125000
Operating cash flow: 18375000
Depreciation & amortization: 12750000
Net tangible assets: 38375000
Owner earnings: 24875000
Return on net tangible assets (%): 64.82084690553745
Capex to operating income (%): 21.120689655172413
Buffett classification: The Great
Stock price: 0.015
P/E ratio: 0.12097829342465752
Shares outstanding: 147190257
Book value: 119750000
P/B ratio: 0.018437192943632566
Market cap (USD): 2207853.855
Debt to equity: 0.826722338204593
Current ratio: 2.2563291139240507
Quick ratio: 1.4050632911392404
Effective tax rate (%): 22.75132275132275
Interest coverage ratio: 5.395348837209302
COGS to revenue (%): 59.79381443298969
SG&A to revenue (%): 30.63917525773196
Free cash flow (dilution-adjusted): 6625000
Buyback yield (%): 266.09551110890897
Retained earnings: 105125000
Inventory turnover: 2.6951672862453533
Receivables turnover: 3.174083769633508
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.77533039647577
FCF margin (%): 2.1855670103092786
Revenue growth (%): 14.578349282296655
Rule of 40 score: 16.763916292605934
Financial ratios for LUCE.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 38375000
Buffett classification: The Gruesome
Stock price: 0.015
Shares outstanding: 147190257
Book value: 119750000
P/B ratio: 0.018437192943632566
Market cap (USD): 2207853.855
Debt to equity: 0.826722338204593
Current ratio: 2.2563291139240507
Quick ratio: 1.4050632911392404
Buyback yield (%): 0
Retained earnings: 105125000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LUCE.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 38356164.38356165
Buffett classification: The Gruesome
Stock price: 0.019726027397260273
Shares outstanding: 147190257
Book value: 126164383.56164384
P/B ratio: 0.02301346037785016
Market cap (USD): 2903479.0421917806
Debt to equity: 0.8154180238870792
Current ratio: 2.251968503937008
Quick ratio: 1.3196850393700787
Buyback yield (%): 0
Retained earnings: 117671232.87671234
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LZM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.91
Shares outstanding: 91209302
Market cap (USD): 903884182.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LZM — annual report dated 2022-12-31
Total revenue: 3527060.2409638558
Gross profit: 3527060.2409638558
Operating income: -30554540.963855423
Net income: -28413665.060240965
Capital expenditures: 6878519.277108434
Operating cash flow: -20524475.903614458
Depreciation & amortization: 383287.9518072289
Net tangible assets: 77187237.3493976
Owner earnings: -34908896.38554217
Return on net tangible assets (%): -45.22625447458719
Buffett classification: The Gruesome
Stock price: 10.38
Shares outstanding: 91209302
Book value: 91550367.46987954
P/B ratio: 10.341329924988948
Market cap (USD): 946752554.7600001
Debt to equity: 0.0052098518946809246
Current ratio: 4.584338461050409
Quick ratio: 4.581361490137467
Interest coverage ratio: -95.21264557693895
COGS to revenue (%): 0
SG&A to revenue (%): 854.7356752953071
Free cash flow (dilution-adjusted): -27959627.710843373
Buyback yield (%): 0
Retained earnings: -53362171.08433735
Inventory turnover: 0
Receivables turnover: 0.05227121113934995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.59365395867773
FCF margin (%): -792.7176118546452
Rule of 40 score: -792.7176118546452
Financial ratios for LZM — annual report dated 2023-12-31
Total revenue: 1870665.82278481
Gross profit: 916344.3037974683
Operating income: -365185830.3797468
Net income: -460600708.8607595
Capital expenditures: 65006705.06329114
Operating cash flow: -34151639.24050633
Depreciation & amortization: 1318932.911392405
Net tangible assets: 136634059.49367088
Owner earnings: -524288481.01265824
Return on net tangible assets (%): -383.71726856065794
Buffett classification: The Gruesome
Stock price: 9.04
Shares outstanding: 91209302
Book value: 162422186.07594937
P/B ratio: 5.0764745260505535
Market cap (USD): 824532090.0799999
Debt to equity: 0.013932295696306439
Current ratio: 4.295223611433097
Quick ratio: 4.287327770100178
Interest coverage ratio: -1360.9688035135557
COGS to revenue (%): 51.015072139751226
SG&A to revenue (%): 19187.698078122863
Free cash flow (dilution-adjusted): -436675564.556962
Buyback yield (%): 0
Retained earnings: -516664762.0253164
Inventory turnover: 7.480789839253821
Receivables turnover: 0.5436091732893883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -222.77974093819276
FCF margin (%): -23343.322962243186
Revenue growth (%): -46.962464631066105
Rule of 40 score: -23390.285426874252
Financial ratios for LZM — annual report dated 2024-12-31
Total revenue: 175652.5
Gross profit: 67062.5
Operating income: -48785795
Net income: -57881548.75
Capital expenditures: 62439376.25
Operating cash flow: -19864760
Depreciation & amortization: 1965627.5
Net tangible assets: 110813340
Owner earnings: -118355297.5
Return on net tangible assets (%): -106.80600142546015
Buffett classification: The Gruesome
Stock price: 6.95
Shares outstanding: 91209302
Book value: 124158751.25
P/B ratio: 5.105597813428395
Market cap (USD): 633904648.9
Debt to equity: 0.2784187957109467
Current ratio: 0.565379017360507
Quick ratio: 0.5624859031131391
Interest coverage ratio: -6.065379397845137
COGS to revenue (%): 61.82092483739201
SG&A to revenue (%): 22642.31152417415
Free cash flow (dilution-adjusted): -105890753.75
Buyback yield (%): 0
Retained earnings: -568088001.25
Inventory turnover: 0.5362336732426359
Receivables turnover: 0.2433530005662916
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -38.77386572370522
FCF margin (%): -60284.22809239835
Revenue growth (%): -90.61016148044493
Rule of 40 score: -60374.83825387879
Financial ratios for LZM — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 126426276.71232878
Buffett classification: The Gruesome
Stock price: 4.12
Shares outstanding: 91209302
Book value: 140535536.98630136
P/B ratio: 2.6739309664902
Market cap (USD): 375782324.24
Debt to equity: 0.30579607115801705
Current ratio: 0.321143309789425
Quick ratio: 0.3159120576377302
Buyback yield (%): 0
Retained earnings: -618855921.9178082
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 217.64
Shares outstanding: 27911655
Market cap (USD): 6074692594.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDP — annual report dated 2022-12-31
Total revenue: 1459996000
Gross profit: 432438000
Operating income: 278697000
Net income: 245368000
Capital expenditures: 36879000
Operating cash flow: 388050000
Depreciation & amortization: 22341000
Net tangible assets: -314017000
Owner earnings: 230830000
Return on net tangible assets (%): -73.50875907992243
Capex to operating income (%): 13.232650512922635
Buffett classification: The Great
Stock price: 212.41
P/E ratio: 24.16254213487496
Shares outstanding: 27911655
Book value: 386387000
P/B ratio: 15.343980616713296
Market cap (USD): 5928714638.55
Debt to equity: 0.4888026771087019
Current ratio: 0.41564961977422926
Quick ratio: 0.41564961977422926
Effective tax rate (%): 13.254613589761718
COGS to revenue (%): 70.38087775582946
SG&A to revenue (%): 9.000024657601802
Free cash flow (dilution-adjusted): 329759000
Buyback yield (%): 14.300722023068403
Retained earnings: -359827000
Receivables turnover: 5.761534940253508
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 50.76216930012295
FCF margin (%): 22.586294756971938
Rule of 40 score: 22.586294756971938
Financial ratios for MEDP — annual report dated 2023-12-31
Total revenue: 1885842000
Gross profit: 524505000
Operating income: 336825000
Net income: 282810000
Capital expenditures: 36648000
Operating cash flow: 433374000
Depreciation & amortization: 26328000
Net tangible assets: -139255000
Owner earnings: 272490000
Return on net tangible assets (%): -195.6769954400201
Capex to operating income (%): 10.880427521710088
Buffett classification: The Great
Stock price: 306.53
P/E ratio: 30.252677087620665
Shares outstanding: 27911655
Book value: 558950000
P/B ratio: 15.306842485284909
Market cap (USD): 8555759607.15
Debt to equity: 0.25426603452902763
Current ratio: 0.6418853113775238
Quick ratio: 0.6418853113775238
Effective tax rate (%): 15.750621123563372
COGS to revenue (%): 72.18722459251623
SG&A to revenue (%): 8.555965982303926
Free cash flow (dilution-adjusted): 376210000
Buyback yield (%): 1.6833105020814672
Retained earnings: -221645000
Receivables turnover: 6.319845844504021
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 46.0333990709269
FCF margin (%): 19.949179199529972
Revenue growth (%): 29.167614157847012
Rule of 40 score: 49.116793357376984
Financial ratios for MEDP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 333.8
Shares outstanding: 27911655
Market cap (USD): 9316910439
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDP — annual report dated 2024-12-31
Total revenue: 2109054000
Gross profit: 656305000
Operating income: 446870000
Net income: 404386000
Capital expenditures: 36548000
Operating cash flow: 608815000
Depreciation & amortization: 29251000
Net tangible assets: 128783000
Owner earnings: 397089000
Return on net tangible assets (%): 308.33961004169805
Capex to operating income (%): 8.178664936111172
Buffett classification: The Great
Stock price: 332.23
P/E ratio: 22.931281351604657
Shares outstanding: 27911655
Book value: 825545000
P/B ratio: 11.232687667722535
Market cap (USD): 9273089140.65
Debt to equity: 0.15290989588695952
Current ratio: 0.9318058979514791
Quick ratio: 0.9318058979514791
Effective tax rate (%): 15.031034497249548
COGS to revenue (%): 68.88154594429541
SG&A to revenue (%): 8.543356405288817
Free cash flow (dilution-adjusted): 546753000
Buyback yield (%): 1.8318275325895674
Retained earnings: 8167000
Receivables turnover: 7.114534666023485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 44.85237069073675
FCF margin (%): 25.92408729221727
Revenue growth (%): 11.836198366565172
Rule of 40 score: 37.76028565878244
Financial ratios for MEDP — quarterly report dated 2024-12-31
Capital expenditures: 7643000
Buffett classification: The Gruesome
Stock price: 332.23
Shares outstanding: 27911655
Market cap (USD): 9273089140.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDP — quarterly report dated 2025-03-31
Total revenue: 558570000
Gross profit: 178350000
Operating income: 113523000
Net income: 114595000
Capital expenditures: 9994000
Operating cash flow: 125836000
Depreciation & amortization: 6930000
Net tangible assets: -102917000
Owner earnings: 111531000
Return on net tangible assets (%): -108.36985143367957
Capex to operating income (%): 8.803502373968271
Buffett classification: The Great
Stock price: 304.69
P/E ratio: 18.553170212378376
Shares outstanding: 27911655
Book value: 593609000
P/B ratio: 14.326605833048353
Market cap (USD): 8504402161.95
Debt to equity: 0.2133727756823094
Current ratio: 0.7319156633054474
Quick ratio: 0.7319156633054474
Effective tax rate (%): 3.0253025302530254
COGS to revenue (%): 68.0702508190558
SG&A to revenue (%): 10.36521832536656
Free cash flow (dilution-adjusted): 98950000
Buyback yield (%): 4.373029319614466
Retained earnings: -269716000
Receivables turnover: 1.873032053839989
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.64703286721768
FCF margin (%): 17.71487906618687
Rule of 40 score: 17.71487906618687
Financial ratios for MEDP — quarterly report dated 2025-06-30
Total revenue: 603311000
Gross profit: 180013000
Operating income: 126335000
Net income: 90260000
Capital expenditures: 6113000
Operating cash flow: 148526000
Depreciation & amortization: 7014000
Net tangible assets: -523938000
Owner earnings: 91161000
Return on net tangible assets (%): -17.399196088086757
Capex to operating income (%): 4.83872244429493
Buffett classification: The Great
Stock price: 313.86
P/E ratio: 42.76367205242733
Shares outstanding: 27911655
Book value: 172351000
P/B ratio: 50.828553581354335
Market cap (USD): 8760352038.300001
Debt to equity: 0.7249508270912266
Current ratio: 0.4267343907089475
Quick ratio: 0.4267343907089475
Effective tax rate (%): 27.524129181454654
COGS to revenue (%): 70.16248667768365
SG&A to revenue (%): 7.734650951167805
Free cash flow (dilution-adjusted): 136462000
Buyback yield (%): 6.174580629124669
Retained earnings: -703215000
Receivables turnover: 1.5963944845615883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 35.96930786094582
FCF margin (%): 22.61884832200971
Revenue growth (%): 8.009918183933975
Rule of 40 score: 30.628766505943688
Financial ratios for MEDP — quarterly report dated 2025-09-30
Total revenue: 659903000
Gross profit: 196939000
Operating income: 141808000
Net income: 111135000
Capital expenditures: 10713000
Operating cash flow: 246209000
Depreciation & amortization: 7049000
Net tangible assets: -402412000
Owner earnings: 107471000
Return on net tangible assets (%): -26.706708547458824
Capex to operating income (%): 7.554580841701456
Buffett classification: The Great
Stock price: 514.16
P/E ratio: 45.416173090287664
Shares outstanding: 27911655
Book value: 293641000
P/B ratio: 48.872795470659746
Market cap (USD): 14351056534.8
Debt to equity: 0.405484928875736
Current ratio: 0.5742479636486556
Quick ratio: 0.5742479636486556
Effective tax rate (%): 22.19398470973704
COGS to revenue (%): 70.15637146671556
SG&A to revenue (%): 7.286222369045148
Free cash flow (dilution-adjusted): 229173000
Buyback yield (%): 0.03187221783224439
Retained earnings: -596237000
Receivables turnover: 1.7690156929395175
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.22993063283152
FCF margin (%): 34.72828582382562
Revenue growth (%): 9.380236726994868
Rule of 40 score: 44.10852255082049
Financial ratios for MEDP — quarterly report dated 2025-12-31
Total revenue: 708450000
Gross profit: 205316000
Operating income: 153269000
Net income: 135133000
Capital expenditures: 4536000
Operating cash flow: 192652000
Depreciation & amortization: 7131000
Net tangible assets: -236745000
Owner earnings: 137728000
Return on net tangible assets (%): -58.17567424866418
Capex to operating income (%): 2.9595025739060086
Buffett classification: The Great
Stock price: 561.65
P/E ratio: 34.75012586534049
Shares outstanding: 27911655
Book value: 459071000
P/B ratio: 34.14848908066508
Market cap (USD): 15676581030.75
Debt to equity: 0.2475499432549649
Current ratio: 0.7364654682276737
Quick ratio: 0.7364654682276737
Effective tax rate (%): 13.836373722367105
COGS to revenue (%): 71.0189851083351
SG&A to revenue (%): 6.340038111369892
Free cash flow (dilution-adjusted): 182496000
Buyback yield (%): 0
Retained earnings: -459981000
Receivables turnover: 1.76197155775745
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.262019489523905
FCF margin (%): 25.75989836968029
Revenue growth (%): 7.356687270704937
Rule of 40 score: 33.116585640385225
Financial ratios for MEDP — annual report dated 2025-12-31
Total revenue: 2530234000
Gross profit: 760618000
Operating income: 534935000
Net income: 451123000
Capital expenditures: 31356000
Operating cash flow: 713223000
Depreciation & amortization: 28124000
Net tangible assets: -236745000
Owner earnings: 447891000
Return on net tangible assets (%): -189.1871000443515
Capex to operating income (%): 5.861646742127548
Buffett classification: The Great
Stock price: 561.65
P/E ratio: 34.75012586534049
Shares outstanding: 27911655
Book value: 459071000
P/B ratio: 34.14848908066508
Market cap (USD): 15676581030.75
Debt to equity: 0.2475499432549649
Current ratio: 0.7364654682276737
Quick ratio: 0.7364654682276737
Effective tax rate (%): 16.82482848645868
COGS to revenue (%): 69.9388277922121
SG&A to revenue (%): 7.80793396974351
Free cash flow (dilution-adjusted): 647081000
Buyback yield (%): 5.851971154938177
Retained earnings: -459981000
Receivables turnover: 6.292893418689906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 84.67859381628686
FCF margin (%): 25.57395877219261
Revenue growth (%): 19.970090855900324
Rule of 40 score: 45.544049628092935
Financial ratios for MEHA — annual report dated 2025-12-31
Total revenue: 6611484
Gross profit: 3483966
Operating income: -1398572
Net income: 758478
Capital expenditures: 8513
Operating cash flow: -1271544
Depreciation & amortization: 399227
Net tangible assets: -674219
Owner earnings: 1149192
Return on net tangible assets (%): -170.4478811780742
Buffett classification: The Gruesome
Stock price: 0.19
P/E ratio: 10.572778880864046
Shares outstanding: 42206422
Book value: 1541331
P/B ratio: 5.202789134845143
Market cap (USD): 8019220.18
Debt to equity: 1.7284768813447597
Current ratio: 0.9021920375424081
Quick ratio: 0.6327158003256996
Interest coverage ratio: -3.4755938150786037
COGS to revenue (%): 47.30432683494356
SG&A to revenue (%): 73.84935061477877
Free cash flow (dilution-adjusted): -1823125
Buyback yield (%): 2.2487223938525154
Retained earnings: -6981325
Inventory turnover: 2.0183903179777363
Receivables turnover: 12.75181397717147
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.646254054977966
FCF margin (%): -27.57512534251009
Revenue growth (%): 0.685742916078767
Rule of 40 score: -26.889382426431325
Financial ratios for MEHA — quarterly report dated 2025-12-31
Total revenue: 1494521
Gross profit: 670755
Operating income: -1132749
Net income: 852315
Capital expenditures: 1
Operating cash flow: -2749902
Depreciation & amortization: 102129
Net tangible assets: -674219
Owner earnings: 954443
Return on net tangible assets (%): -141.56275631508458
Buffett classification: The Gruesome
Stock price: 0.19
P/E ratio: 10.572778880864046
Shares outstanding: 42206422
Book value: 1541331
P/B ratio: 5.202789134845143
Market cap (USD): 8019220.18
Debt to equity: 1.7284768813447597
Current ratio: 0.9021920375424081
Quick ratio: 0.6327158003256996
Interest coverage ratio: -13.987836653042072
COGS to revenue (%): 55.1190649044075
SG&A to revenue (%): 120.67438329739093
Free cash flow (dilution-adjusted): -2694115
Buyback yield (%): 0
Retained earnings: -6981325
Inventory turnover: 0.5316296560656878
Receivables turnover: 2.882537986475696
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.73065715209674
FCF margin (%): -180.26611870960662
Revenue growth (%): -11.784680912350206
Rule of 40 score: -192.05079962195683
Financial ratios for MELI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1348.4
Shares outstanding: 50697182
Market cap (USD): 68360080208.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MELI — annual report dated 2022-12-31
Total revenue: 272980501.39275765
Gross profit: 131628260.31906812
Operating income: 27070144.340339325
Net income: 12205621.676373765
Capital expenditures: 11521904.279564446
Operating cash flow: 74449227.65257026
Depreciation & amortization: 10205115.219042795
Net tangible assets: 41757406.93846543
Owner earnings: 10888832.615852112
Return on net tangible assets (%): 26.076409945421464
Capex to operating income (%): 42.56314312441534
Buffett classification: The Good
Stock price: 846.24
P/E ratio: 3514.9363492663965
Shares outstanding: 50697182
Book value: 46264877.18409723
P/B ratio: 927.3121622038333
Market cap (USD): 42901983295.68
Debt to equity: 2.9633278598795845
Current ratio: 1.2792571829011912
Quick ratio: 1.2615043214202288
Effective tax rate (%): 38.205128205128204
Interest coverage ratio: 7.9185185185185185
COGS to revenue (%): 51.78107606679034
R&D to revenue (%): 10.194805194805195
SG&A to revenue (%): 18.15398886827458
Free cash flow (dilution-adjusted): 62902000.50645733
Buyback yield (%): 0.008735689964138298
Retained earnings: 23119777.158774372
Inventory turnover: 36.723684210526315
Receivables turnover: 2.1668341708542713
Capitalized R&D asset: 27829830.336794123
ROCI (R&D-adjusted, %): 28.72097348424465
FCF margin (%): 23.042671614100186
Rule of 40 score: 23.042671614100186
Financial ratios for MELI — annual report dated 2023-12-31
Total revenue: 388554526.74897116
Gross profit: 195216049.38271603
Operating income: 56764403.29218107
Net income: 25385802.469135802
Capital expenditures: 13091563.78600823
Operating cash flow: 132201646.09053497
Depreciation & amortization: 13477366.255144032
Net tangible assets: 73894032.9218107
Owner earnings: 25771604.938271604
Return on net tangible assets (%): 34.87643578141316
Capex to operating income (%): 23.062981422745807
Buffett classification: The Great
Stock price: 1571.54
P/E ratio: 3138.472754491273
Shares outstanding: 50697182
Book value: 78986625.51440328
P/B ratio: 1008.6853170572734
Market cap (USD): 79672649400.28
Debt to equity: 1.7365678931943993
Current ratio: 1.2660925153156353
Quick ratio: 1.2449613779632425
Effective tax rate (%): 36.638763683193815
Interest coverage ratio: 12.683908045977011
COGS to revenue (%): 49.75839015026147
R&D to revenue (%): 12.120209174554843
SG&A to revenue (%): 16.561858740981002
Free cash flow (dilution-adjusted): 114814814.8148148
Buyback yield (%): 0.01149249920737651
Retained earnings: 48894032.921810694
Inventory turnover: 31.584033613445378
Receivables turnover: 2.303949977123685
Capitalized R&D asset: 65739607.72482902
ROCI (R&D-adjusted, %): 34.441406372965574
Rosenberg metric: 2.2848787899212524
FCF margin (%): 29.54921559541934
Revenue growth (%): 42.337831737633316
Rule of 40 score: 71.88704733305266
Financial ratios for MELI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2051.96
Shares outstanding: 50697182
Market cap (USD): 104028589576.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MELI — annual report dated 2024-12-31
Total revenue: 480282015.71890897
Gross profit: 221382339.3435044
Operating income: 60818307.90568655
Net income: 44174757.2815534
Capital expenditures: 19879796.578825705
Operating cash flow: 183032824.7803976
Depreciation & amortization: 14262598.243180769
Net tangible assets: 95723532.13129912
Owner earnings: 38557558.945908464
Return on net tangible assets (%): 40.28012557353296
Capex to operating income (%): 32.68719118206005
Buffett classification: The Good
Stock price: 1700.44
P/E ratio: 1951.5108053820306
Shares outstanding: 50697182
Book value: 100577901.06333792
P/B ratio: 857.1218453424643
Market cap (USD): 86207516160.08
Debt to equity: 1.5743507239715013
Current ratio: 1.2131542492320666
Quick ratio: 1.195326145877251
Effective tax rate (%): 21.422697368421055
Interest coverage ratio: 15.945454545454545
COGS to revenue (%): 53.905761178225916
R&D to revenue (%): 9.308369832025798
SG&A to revenue (%): 15.180247388939694
Free cash flow (dilution-adjusted): 163153028.2015719
Buyback yield (%): 2.681441661141674e-05
Retained earnings: 88118354.13777162
Inventory turnover: 37.83783783783784
Receivables turnover: 1.9834844868735084
Capitalized R&D asset: 85442996.60841495
ROCI (R&D-adjusted, %): 23.109090598183247
Rosenberg metric: 0.5556228037550256
FCF margin (%): 33.97025557106416
Revenue growth (%): 23.607365930702205
Rule of 40 score: 57.57762150176636
Financial ratios for MELI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1700.44
Shares outstanding: 50697182
Market cap (USD): 86207516160.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MELI — quarterly report dated 2025-03-31
Total revenue: 144298565.52394846
Gross profit: 67371748.11573061
Operating income: 18550936.056406517
Net income: 12010697.787503038
Capital expenditures: 6613177.729151471
Operating cash flow: 25066861.17189399
Depreciation & amortization: 4181862.3875516653
Net tangible assets: 115657670.79990274
Owner earnings: 9579382.445903232
Return on net tangible assets (%): 8.282531006937145
Capex to operating income (%): 35.648754914809956
Buffett classification: The Good
Stock price: 1950.87
P/E ratio: 2058.656649225822
Shares outstanding: 50697182
Book value: 121663019.6936543
P/B ratio: 812.9307631635137
Market cap (USD): 98903611448.34
Debt to equity: 1.5437649880095918
Current ratio: 1.2034320509272074
Quick ratio: 1.183614724605591
Effective tax rate (%): 30.028328611898015
Interest coverage ratio: 19.564102564102566
COGS to revenue (%): 53.31086773378264
R&D to revenue (%): 9.283909014321818
SG&A to revenue (%): 14.389216512215667
Free cash flow (dilution-adjusted): 18453683.442742523
Buyback yield (%): 0
Retained earnings: 104692438.60928762
Inventory turnover: 8.837988826815643
Receivables turnover: 0.5255002656277671
Capitalized R&D asset: 13396547.532214927
ROCI (R&D-adjusted, %): 11.116574875426174
FCF margin (%): 12.788542544229148
Rule of 40 score: 12.788542544229148
Financial ratios for MELI — quarterly report dated 2025-06-30
Total revenue: 170860593.86009058
Gross profit: 77856064.41872169
Operating income: 20759939.607448414
Net income: 13160543.532964267
Capital expenditures: 7221942.627075993
Operating cash flow: 73402113.73930548
Depreciation & amortization: 5007549.068948163
Net tangible assets: 137015601.40915954
Owner earnings: 10946149.974836439
Return on net tangible assets (%): 7.988980716253445
Capex to operating income (%): 34.78787878787878
Buffett classification: The Good
Stock price: 2613.63
P/E ratio: 5264.089843790035
Shares outstanding: 50697182
Book value: 143759436.33618522
P/B ratio: 921.7041967304092
Market cap (USD): 132503675790.66
Debt to equity: 1.5716786276912305
Current ratio: 1.1982528735632185
Quick ratio: 1.1782988505747127
Effective tax rate (%): 26.955307262569832
Interest coverage ratio: 22.916666666666668
COGS to revenue (%): 54.43298969072165
R&D to revenue (%): 8.350515463917525
SG&A to revenue (%): 14.904270986745214
Free cash flow (dilution-adjusted): 66180171.11222949
Buyback yield (%): 0
Retained earnings: 121514846.50226471
Inventory turnover: 8.516129032258064
Receivables turnover: 0.5040083135391924
Capitalized R&D asset: 23243427.158612184
ROCI (R&D-adjusted, %): 8.46037210373725
Rosenberg metric: 0.7826133022541254
FCF margin (%): 38.733431516936676
Revenue growth (%): 18.40768703395999
Rule of 40 score: 57.141118550896664
Financial ratios for MELI — quarterly report dated 2025-09-30
Total revenue: 188141188.420518
Gross profit: 81488065.00761807
Operating income: 18384966.988318942
Net income: 10690705.942102589
Capital expenditures: 9065515.490096495
Operating cash flow: 75139664.80446927
Depreciation & amortization: 5307262.569832402
Net tangible assets: 150863382.42762822
Owner earnings: 6932453.021838497
Return on net tangible assets (%): 4.595185995623633
Capex to operating income (%): 49.30939226519337
Buffett classification: The Good
Stock price: 2336.94
P/E ratio: 3303.6765024395927
Shares outstanding: 50697182
Book value: 157897409.85271716
P/B ratio: 750.3370233469426
Market cap (USD): 118476272503.08
Debt to equity: 1.5884528787391439
Current ratio: 1.1742516923578827
Quick ratio: 1.1525568876926842
Effective tax rate (%): 33.80503144654089
Interest coverage ratio: 20.685714285714287
COGS to revenue (%): 56.68781212039412
R&D to revenue (%): 7.652854636253206
SG&A to revenue (%): 14.887299230665407
Free cash flow (dilution-adjusted): 66074149.31437277
Buyback yield (%): 2.1433490669564298e-05
Retained earnings: 133316404.26612493
Inventory turnover: 7.894736842105263
Receivables turnover: 0.5021008403361344
Capitalized R&D asset: 28378418.355431303
ROCI (R&D-adjusted, %): 5.560966190539733
Rosenberg metric: 0.25456032346162627
FCF margin (%): 35.11944931839655
Revenue growth (%): 10.113856079990956
Rule of 40 score: 45.2333053983875
Financial ratios for MELI — annual report dated 2025-12-31
Total revenue: 747554980.5950841
Gross profit: 332677878.3958603
Operating income: 82820181.11254852
Net income: 51668822.76843467
Capital expenditures: 34747736.0931436
Operating cash flow: 313479948.25355756
Depreciation & amortization: 21164294.954721864
Net tangible assets: 169521345.40750325
Owner earnings: 38085381.630012944
Return on net tangible assets (%): 22.46642246642247
Capex to operating income (%): 41.95563886285536
Buffett classification: The Good
Stock price: 2014.26
P/E ratio: 1976.3815071417716
Shares outstanding: 50697182
Book value: 174592496.76584733
P/B ratio: 584.8894294253288
Market cap (USD): 102117305815.31999
Debt to equity: 1.6882039122703025
Current ratio: 1.172528201725282
Quick ratio: 1.1526211015262111
Effective tax rate (%): 29.73258268824771
Interest coverage ratio: 20.00625
COGS to revenue (%): 55.49787145675423
R&D to revenue (%): 7.8531132108123085
SG&A to revenue (%): 14.872114352957466
Free cash flow (dilution-adjusted): 278732212.160414
Buyback yield (%): 2.5336764429364534e-05
Retained earnings: 150297542.04398447
Inventory turnover: 28.13157894736842
Receivables turnover: 1.7414863480200107
Capitalized R&D asset: 104200539.59500861
ROCI (R&D-adjusted, %): 19.549900120646388
Rosenberg metric: 2.4894751910056447
FCF margin (%): 37.28584778320009
Revenue growth (%): 55.64917197161926
Rule of 40 score: 92.93501975481935
Financial ratios for MELI — quarterly report dated 2025-12-31
Total revenue: 226623544.63130662
Gross profit: 97904269.08150065
Operating income: 23001293.661060803
Net income: 14463130.659767142
Capital expenditures: 11047865.459249677
Operating cash flow: 134773609.31435964
Depreciation & amortization: 6157826.649417853
Net tangible assets: 169521345.40750325
Owner earnings: 9573091.849935317
Return on net tangible assets (%): 5.6471306471306475
Capex to operating income (%): 48.03149606299213
Buffett classification: The Good
Stock price: 2014.26
P/E ratio: 2029.1534565114848
Shares outstanding: 50697182
Book value: 174592496.76584733
P/B ratio: 584.8894294253288
Market cap (USD): 102117305815.31999
Debt to equity: 1.6882039122703025
Current ratio: 1.172528201725282
Quick ratio: 1.1526211015262111
Effective tax rate (%): 28.698979591836732
Interest coverage ratio: 17.779999999999998
COGS to revenue (%): 56.79872131521863
R&D to revenue (%): 6.667427788560337
SG&A to revenue (%): 15.161548121931725
Free cash flow (dilution-adjusted): 123725743.85510996
Buyback yield (%): 0
Retained earnings: 150297542.04398447
Inventory turnover: 8.728070175438596
Receivables turnover: 0.5279368332228317
Capitalized R&D asset: 29465090.505834274
ROCI (R&D-adjusted, %): 5.99111101108472
Rosenberg metric: 1.1401589355017565
FCF margin (%): 54.59527343304029
Revenue growth (%): 20.4539774271947
Rule of 40 score: 75.04925086023499
Financial ratios for MLHCF.PA — annual report dated 2022-12-31
Total revenue: 2136175.5319148935
Gross profit: 613468.085106383
Operating income: 712477.6595744682
Net income: 822728.7234042553
Capital expenditures: 0
Depreciation & amortization: 19501.063829787236
Owner earnings: 842229.7872340425
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.563829787234043
P/E ratio: 17.56663153879475
Shares outstanding: 928600
Market cap (USD): 14452572.340425532
Interest coverage ratio: 1.624944499035557
COGS to revenue (%): 71.2819440190637
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLHCF.PA — annual report dated 2023-12-31
Total revenue: 2324181.111111111
Gross profit: 1022830
Operating income: 1224845.5555555555
Net income: 418932.2222222222
Capital expenditures: 0
Depreciation & amortization: 20975.555555555555
Net tangible assets: 15686483.333333332
Owner earnings: 439907.77777777775
Return on net tangible assets (%): 2.804374750094473
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.688888888888886
P/E ratio: 36.99238540310154
Shares outstanding: 928600
Book value: 15692900.000000004
P/B ratio: 0.98753590618829
Market cap (USD): 15497302.22222222
Debt to equity: 1.3870766043525695
Current ratio: 45.544925344519925
Quick ratio: 3.863446901901478
Interest coverage ratio: 1.3414814012551277
COGS to revenue (%): 55.99181169185993
Buyback yield (%): 0
Retained earnings: 2899203.3333333335
Inventory turnover: 0.03767188487407962
Receivables turnover: 2.666442738282958
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.269625289880303
Revenue growth (%): 8.80103607533071
Rule of 40 score: 8.80103607533071
Financial ratios for MODE.L — annual report dated 2021-12-31
Total revenue: 1774324.3243243243
Gross profit: 218918.91891891893
Operating income: -12459459.45945946
Net income: -12089189.18918919
Capital expenditures: 39189.18918918919
Operating cash flow: -10904054.054054054
Depreciation & amortization: 37837.83783783784
Net tangible assets: 6170270.27027027
Owner earnings: -12090540.540540542
Return on net tangible assets (%): -195.94831362242667
Buffett classification: The Gruesome
Stock price: 0.0029729729729729734
Shares outstanding: 107411062
Book value: 6247297.297297297
P/B ratio: 0.05111493324680944
Market cap (USD): 319330.18432432436
Debt to equity: 0
Current ratio: 4.376768428890544
Quick ratio: 4.376768428890544
COGS to revenue (%): 87.66184310738767
SG&A to revenue (%): 641.8126428027418
Free cash flow (dilution-adjusted): -14559459.45945946
Buyback yield (%): 0
Retained earnings: -19890540.540540542
Receivables turnover: 101
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -199.39446366782002
FCF margin (%): -820.5635948210206
Rule of 40 score: -820.5635948210206